서울대학교 중앙도서관

S-Space 소개

My S-Space

로그인이 필요합니다.

Login

S-Space

Browse

Subject

Jump to a point in the index

Or type in a year

Sort by
In order
Results/Page
Authors/record

Showing results 1 to 11 of 11

Issue Date	Title / Author(s) / Citation	File	Altmetrics
2009	The Anti-inflammatory Effect of Subconjunctival Bevacizumab on Chemically Burned Rat Corneas Oh, Joo Youn; Kim, Mee Kum; Shin, Mi Sun; Lee, Hyun Ju; Wee, Won Ryang; Lee, Jin Hak CURRENT EYE RESEARCH; Vol.34 2; 85-91	DOI
2009-02	The Anti-inflammatory Effect of Subconjunctival Bevacizumab on Chemically Burned Rat Corneas Oh, Joo Youn; Kim, Mee Kum; Shin, Mi Sun; Lee, Hyun Ju; Lee, Jin Hak; Wee, Won Ryang Current Eye Research, Vol.34 No.2, pp.85-91	DOI
2009-10	Subconjunctival and Intracorneal Bevacizumab Injection for Corneal Neovascularization in Lipid Keratopathy Oh, Joo Youn; Kim, Mee Kum; Wee, Won Ryang Cornea, Vol.28 No.9, pp.1070-1073	DOI
2009-10	Subconjunctival and Intracorneal Bevacizumab Injection for Corneal Neovascularization in Lipid Keratopathy Oh, Joo Youn; Kim, Mee Kum; Wee, Won Ryang CORNEA; Vol.28 9; 1070-1073	DOI
2011-02	Visual outcome with photodynamic therapy, anti-VEGF therapy and their combination for polypoidal choroidal vasculopathy 이선호	link
2013-06	Multicentre phase II trial of bevacizumab combined with docetaxel-carboplatin for the neoadjuvant treatment of triple-negative breast cancer (KCSG BR-0905) Kim, H. R.; Jung, K. H.; Im, S. -A.; Im, Y. -H.; Kang, S. Y.; Park, K. H.; Lee, S.; Kim, S. -B.; Lee, K. -H.; Ahn, J. S.; Kim, S. I.; Sohn, J. H. Annals of Oncology, Vol.24 No.6, pp.1485-1490	DOI
2014-02	A Phase II Study of Bevacizumab, Oxaliplatin, and Capecitabine in Patients With Previously Untreated Metastatic Colorectal Cancer A Prospective, Multicenter Trial of the Korean Cancer Study Group Hong, Yong Sang; Lee, Sung Sook; Kim, Kyu-pyo; Lee, Jae-Lyun; Kang, Yoon-Koo; Shin, Sang Joon; Ahn, Joong Bae; Jung, Kyung Hae; Im, Seock-Ah; Kim, Tae-You; Kim, Jee Hyun; Park, Young Suk; Kim, Tae Won American Journal of Clinical Oncology, Vol.37 No.1, pp.19-23	DOI
2020-02	Bevacizumab as adjuvant treatment of colon cancer: updated results from the S-AVANT phase III study by the GERCOR Group Andre, T.; Vernerey, D.; Im, S. A.; Bodoky, G.; Buzzoni, R.; Reingold, S.; Rivera, F.; McKendrick, J.; Scheithauer, W.; Ravit, G.; Fountzilas, G.; Yong, W. P.; Isaacs, R.; Osterlund, P.; Liang, J. T.; Creemers, G. J.; Rakez, M.; Van Cutsem, E.; Cunningham, D.; Tabernero, J.; de Gramont, A. Annals of Oncology, Vol.31 No.2, pp.246-256	DOI
2020-03	Effect of a Single Intravitreal Bevacizumab Injection on Proteinuria in Patients With Diabetes Chung, Yoo-Ri; Kim, Young Ho; Byeon, Hye-Eun; Jo, Dong Hyun; Kim, Jeong Hun; Lee, Kihwang Translational Vision Science & Technology, Vol.9 No.4, p. 4	DOI
2022	Optimal cytoreduction and platinum-free interval affecting the duration of bevacizumab-based maintenance therapy and prognosis in the first platinum-sensitive recurrence of ovarian cancer 오수현	view file link
2022	Real-world treatment burden and patterns of patients with myopic choroidal neovascularization: Common Data Model in Ophthalmology 만헝	view file link

1